Zydus Wellness Limited reported its audited financial results for the quarter and full year ended March 31, 2026. The consolidated results reflect a significant expansion in the company's top line, driven by the acquisition of Comfort Click Limited (CCL), even as net profit moderated on a year-on-year basis due to higher operating costs and exceptional items. The Board of Directors recommended a final dividend of ₹1.20 per equity share, subject to shareholder approval. Management expressed optimism about the company's growth trajectory, targeting EBITDA margins of 17-18% in the next few years, excluding the Comfort Click business, and confirmed full-year guidance.

Consolidated Financial Performance

Consolidated net sales for Q4 FY26 stood at ₹14,761 million, registering a growth of 62.1% compared to ₹9,106 million in the corresponding period of the previous year. For the full year FY26, consolidated net sales reached ₹39,400 million, reflecting a year-on-year growth of 46.4%. EBITDA for FY26 stood at ₹5,097 million, growing 34.20% year-on-year, which includes the post-acquisition performance of the newly acquired CCL business. PAT for FY26 stood at ₹1,972 million.

Consolidated total revenue from operations rose to ₹39,610 million for the full year, compared to ₹27,089 million in the previous year. Total income for the year stood at ₹39,674 million versus ₹27,225 million in the prior year. Consolidated net profit declined to ₹1,972 million from ₹3,469 million year-on-year, reflecting higher operating costs, increased finance charges, and exceptional items totalling ₹408 million. Total comprehensive income for the year came in at ₹1,926 million, compared to ₹3,459 million in the previous year.

The following table presents the key consolidated financial metrics:

Management Outlook and Guidance

Management confirmed full-year guidance and expressed confidence in the company's growth prospects. The company is targeting EBITDA margins of 17-18% in the next few years, excluding the Comfort Click business. Comfort Click's margins met or slightly exceeded expectations, with the business turning EPS accretive in Q4. On the seasonal portfolio, management expects steady double-digit growth over the next three to four years, despite recent challenges. Regarding taxation, the company expects tax rates for FY27-28 to be 25%, while FY26-27 will utilise a combination of cash and deferred tax assets.

Segment and Business Performance

The company's domestic business saw varied performance across categories. The Food and Nutrition segment reported growth of 9.4% in Q4 FY26 and 15.5% for the full year. The Skin and Hair Care segment grew by 39.7% in Q4 and 21.9% in FY26. However, the Seasonal Brands segment reported a decline of 9.8% in Q4 and 18.8% for the full year. International business, excluding Comfort Click, delivered high double-digit topline growth despite geopolitical disruptions.

Brand Highlights

Across its portfolio, Zydus Wellness reported strong brand-level developments during the quarter and full year. The following table summarises key market share positions and notable launches:

Source: MAT March '26 report of Nielsen & IQVIA

Exceptional Items and Corporate Developments

Consolidated exceptional items for the full year amounted to ₹408 million. These included expenses related to the liquidation of Naturell (India) Private Limited (NIPL) (₹97 million), acquisition-related expenses for CCL (₹245 million), and a one-time impact of New Labour Codes (₹66 million). The acquisition of CCL by Alidac UK Limited, a wholly owned subsidiary, was a major development. The cost of acquisition was GBP 239 million, with results including CCL's operations effective from August 29, 2025.

Balance Sheet and Dividend

Consolidated total assets expanded to ₹1,03,078 million as at March 31, 2026, from ₹64,419 million a year ago, primarily due to goodwill and intangible assets from the CCL acquisition. Non-current borrowings rose to ₹30,349 million from nil in the previous year. The Board recommended a final dividend of ₹1.20 per equity share of ₹2 each, subject to approval at the Annual General Meeting on August 4, 2026.

Zydus Wellness Limited has fixed Friday, July 17, 2026, as the record date to determine the eligibility of members entitled to receive the final dividend for the financial year ended March 31, 2026. The Board of Directors has recommended a final dividend of ₹1.20 per equity share, which is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).

Key Meeting Dates

The company has scheduled its Thirty Second AGM for Tuesday, August 4, 2026, at 10:00 a.m. IST via Video Conference or Other Audio Visual Means. Following the meeting, the payment of the dividend is expected to commence on or after Friday, August 7, 2026, subject to the deduction of applicable tax at source and shareholder approval.

Board Appointments

During its meeting held on May 18, 2026, the board approved the appointment of Mr. Apurva S. Diwanji as an Additional Director in the category of Non-Executive & Independent Director. His appointment is effective May 18, 2026, for a term of five years ending May 17, 2031, subject to approval by members through a special resolution. Mr. Diwanji will not be liable to retire by rotation.

Corporate Calendar

Mr. Apurva S. Diwanji brings over 32 years of experience, specializing in mergers and acquisitions, private equity, and joint ventures. He currently serves as an Independent Director on the boards of Torrent Power Limited, Bajaj Life Insurance Limited, and Bajaj General Insurance Limited, among others.